MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
MGNX earnings call for the period ending December 31, 2023.
MacroGenics (MGNX) Q3 2023 Earnings Call Transcript
MGNX earnings call for the period ending September 30, 2023.
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...
3 Under-the-Radar Biotech Stocks to Buy in 2023
All three biotech companies focus on oncology therapies.
Why Shares of MacroGenics Are Jumping Thursday
The company announced second-quarter earnings.
MacroGenics (MGNX) Q2 2023 Earnings Call Transcript
MGNX earnings call for the period ending June 30, 2023.
MacroGenics (MGNX) Q1 2023 Earnings Call Transcript
MGNX earnings call for the period ending March 31, 2023.
MacroGenics (MGNX) Reports Q1 Loss, Misses Revenue Estimates
MacroGenics (MGNX) delivered earnings and revenue surprises of -157.01% and 81.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?